Formulation development and evaluation of Silybum marianum tablets

Prepared tablets from Silybum marianum ethanolic extract

In popular medicine Silybum marianum is used as a hepatoprotective agent. Silymarin is the major constituent. The present work deals with the formulation and evaluation of S. marianum tablets from ethanolic extract by direct compression. The ethanolic extract was obtained from seeds by soxhlet extraction. Two pharmaceutical formulations were prepared using fluid extract as an active principle, and Aeroperl® 300 Pharma as a carrier. In order to improve flow ability and compressibility, co-processed excipients MicroceLac® 100 and FlowLac® 90 were employed. Pre-compression and post-compression parameters were evaluated according to USP 34-NF 29. Besides, silymarin was determined by NMR spectral data. Both formulations showed excellent rheological properties and the best biopharmaceutical parameters were observed in F2 (S. marianum ethanolic extract, aeroperl® 300 Pharma, flowLac® 90, glycolate starch and magnesium stearate) in terms of the friability (0.82 %) and the disintegration time (8.05 min).

Access the full publication

Investigation of the Electrokinetic Potential of Granules and Optimization of the Pelletization Method Using the Quality by Design Approach

Fungal Infections: Effect of Eudragit RL-100 Based Miconazole Film Forming Spray

Quality Assesment and Stability Studies of Metronidazole Tablets Formulations Obtained via Crystallo Co-Agglomeration Technique

Key words: direct compression; ethanolic extract; herbal tablets; quality controls; Silybum marianum

Pharmacognosy • Rodriguésia 71 • 2020 • https://doi.org/10.1590/2175-7860202071044, Formulation development and evaluation of Silybum marianum tablets, Valeria Andrea CianchinoLaura Silvina FavierClaudia Alicia OrtegaCecilia PeraltaDiego Alberto Cifuente

excipients formulation